Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
View: Text | PDF
Research Article Autoimmunity Metabolism

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease

  • Text
  • PDF
Abstract

Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases. The SKIV2L RNA exosome is cytoplasmic RNA degradation machinery that was thought to be essential for preventing the self-RNA–mediated interferon (IFN) response. Here, we demonstrate the physiological function of SKIV2L in mammals. We found that Skiv2l deficiency in mice disrupted epidermal and T cell homeostasis in a cell-intrinsic manner independently of IFN. Skiv2l-deficient mice developed skin inflammation and hair abnormality, which were also observed in a SKIV2L-deficient patient. Epidermis-specific deletion of Skiv2l caused hyperproliferation of keratinocytes and disrupted epidermal stratification, leading to impaired skin barrier with no appreciable IFN activation. Moreover, Skiv2l-deficient T cells were chronically hyperactivated and these T cells attacked lesional skin as well as hair follicles. Mechanistically, SKIV2L loss activated the mTORC1 pathway in both keratinocytes and T cells. Both systemic and topical rapamycin treatment of Skiv2l-deficient mice ameliorated epidermal hyperplasia and skin inflammation. Together, we demonstrate that mTORC1, a classical nutrient sensor, also senses cytoplasmic RNA quality control failure and drives autoinflammatory disease. We also propose SKIV2L-associated trichohepatoenteric syndrome (THES) as a new mTORopathy for which sirolimus may be a promising therapy.

Authors

Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan

×

Figure 5

T cell immune homeostasis is disrupted in postnatal whole-body inducible Skiv2l knockout mice.

Options: View larger image (or click on image) Download as PowerPoint
T cell immune homeostasis is disrupted in postnatal whole-body inducible...
(A) Flow cytometry analysis of iSkiv2l–/– (n = 5) and Skiv2lfl/fl (n = 6) splenic T cells. Numbers adjacent to each gate indicate the percentage of each population. Two-sided Student’s t test, **P < 0.01, ***P < 0.001. (B) BrdU staining of iSkiv2l–/– and Skiv2lfl/fl littermates splenocytes 20 hours after injection of BrdU (n = 6 mice per genotype). Numbers adjacent to gates (left) in dot plot indicate the percentage of BrdU-positive cells. Two-sided Student’s t test, **P < 0.01, ***P < 0.001. (C) T cell activation analysis. iSkiv2l–/– and Skiv2lfl/fl splenic CD8+ T cells were stimulated for 16 hours with indicated concentration of anti-CD3 and anti-CD28 antibodies followed by FACS analysis of activation markers CD69 and CD25. Two-sided Student’s t test, *P < 0.05, **P < 0.01, ***P < 0.001. (D) T cell proliferation analysis by the CFSE dilution assay. iSkiv2l–/– and Skiv2lfl/fl splenic CD8+ T cells were stained with CFSE then stimulated with anti-CD3 and anti-CD28 (3 μg/mL) for indicated times. Two-sided Student’s t test, ***P < 0.001. (E) Phosphorylation of S6 ribosomal protein (S235/236) in iSkiv2l–/– and Skiv2lfl/fl splenic T cells. Dashed lines, isotype control (iso). n = 4 per genotype. Two-sided Student’s t test, **P < 0.01, ***P < 0.001. (F) Flow cytometry analysis of T cell size (indicated by FSC). Splenic T cells were isolated from iSkiv2l–/– and Skiv2lfl/fl mice followed by FACS analysis.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts